[Pharmacokinetics of bacampicillin in man (author's transl)]. 1979

W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
December 1980, Der Anaesthesist,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
December 1980, La Nouvelle presse medicale,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
June 1981, Der Anaesthesist,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
October 1980, Masui. The Japanese journal of anesthesiology,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
April 1979, The Japanese journal of antibiotics,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
January 1980, Therapie,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
January 1980, Arzneimittel-Forschung,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
January 1977, Arzneimittel-Forschung,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
January 1982, Arzneimittel-Forschung,
W Schnyder, and M Rudhardt, and L Balant, and J Fabre, and J Estreicher
January 1976, Arzneimittel-Forschung,
Copied contents to your clipboard!